PricewaterhouseCoopers: The most popular medical hotspots for global CEOs in 2017 are here.

PricewaterhouseCoopers: The most popular medical hotspots for global CEOs in 2017 are here.

PricewaterhouseCoopers recently released the 20th Global CEO Annual Survey for the major findings of the medical industry. The survey interviewed 56 medical industry CEOs from 27 countries and discussed in depth the topics of 2017, including globalization, technology innovation, talent and trust.

In the context of globalization, government regulation continues to be a hot spot of concern
Consistent with last year, over-regulation has become the most concerned issue for executives, with a ratio of 84%. Uncertain economic growth and geopolitical uncertainty are closely followed, with 82% and 80% respectively. Given the special nature of the medical market, this result is not surprising.
Although CEOs are more worried about the overall situation, they are still optimistic about the business prospects of their companies. 52% of medical industry CEOs are very confident about future company revenue growth prospects.


Technology and innovation bring danger to the machine
In the medical industry, a quarter of CEOs believe that technology will completely change the competition in the next five years, while only 2% of CEOs believe that technology will not affect the industry's competitive situation. In addition, 71% of respondents are concerned about the speed of technological change, while 70% of respondents are concerned about changing consumer behavior.


Technological reform promotes talent transformation
The gradual integration of technology and talent is a new theme in the global CEO annual survey over the past few years. As automation and machines are able to take on more and more jobs, many companies are restructuring their workforce structures, and the functions of each job are changing. In this year's survey, 79% of respondents in the medical industry said they have adjusted their talent strategy to accommodate the skills and employment structures needed in the future, which is consistent with the global CEO average.
In reality, however, most global CEOs are planning to increase their staff this year instead of reducing their employees. The proportion of CEOs in the medical industry is significantly higher than the average: 64% of medical industry CEOs plan to hire more employees in the next 12 months. The ratio is the highest in all industries, while the global CEO is 52%. However, 59% of CEOs in the industry have begun to study the benefits of working with people and machines (compared to a global average of 52%), and 52% of respondents are considering the impact of artificial intelligence on future skill needs. This is also far higher than the global average of 39%.


Cybersecurity becomes a major threat to maintain trust
Now, trust is gradually attracting more and more attention, and this is also an area where digital technology will not solve it and will only cause more problems: 75% of medical industry CEOs believe that enterprises are increasingly difficult to establish in the new digital age. And maintain trust. In the eyes of all respondents in the medical industry, violations of data privacy ethics are the primary threat to stakeholder trust in the next five years, at a rate of 82%. Given the high sensitivity of the data handled by the medical industry, the above results are not surprising.
As one of the CEOs interviewed, Caesar Medical Group CEO Bernard Tyson said: “Trust is extremely important. You never want to lose faith, because the doctor-patient relationship is probably the closest relationship, and the relationship is contacted. It is the reality and fragility of human life."

Edible Mushrooms

Edible Mushroom Extract,Hericium Erinaceus Extract,Boletus Extract

Fufeng Sinuote Biotechnology Co.,Ltd. , https://www.sinuotebio.com